Skip to main content
Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.470
-0.090 (-5.77%)
Mar 11, 2025, 4:00 PM EST - Market closed

Editas Medicine Operating Expense Breakdown
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Research and Development
199.25M 220.19M 213.07M 188.63M 177.65M 160.09M 160.91M 174.79M
Research and Development Growth
12.16% 37.54% 32.41% 7.92% 1.54% -0.26% 8.39% 26.16%
General and Administrative
71.99M 70.09M 66.99M 65.98M 69.65M 73.18M 74.43M 74.17M
General and Administrative Growth
3.35% -4.23% -10.00% -11.03% -1.49% 5.69% 7.57% -0.16%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.